» Articles » PMID: 34360142

COVID-19 Prevention and Control Measures in Workplace Settings: A Rapid Review and Meta-Analysis

Abstract

Workplaces can be high-risk environments for SARS-CoV-2 outbreaks and subsequent community transmission. Identifying, understanding, and implementing effective workplace SARS-CoV-2 infection prevention and control (IPC) measures is critical to protect workers, their families, and communities. A rapid review and meta-analysis were conducted to synthesize evidence assessing the effectiveness of COVID-19 IPC measures implemented in global workplace settings through April 2021. Medline, Embase, PubMed, and Cochrane Library were searched for studies that quantitatively assessed the effectiveness of workplace COVID-19 IPC measures. The included studies comprised varying empirical designs and occupational settings. Measures of interest included surveillance measures, outbreak investigations, environmental adjustments, personal protective equipment (PPE), changes in work arrangements, and worker education. Sixty-one studies from healthcare, nursing home, meatpacking, manufacturing, and office settings were included, accounting for ~280,000 employees based in Europe, Asia, and North America. Meta-analyses showed that combined IPC measures resulted in lower employee COVID-19 positivity rates (0.2% positivity; 95% CI 0-0.4%) than single measures such as asymptomatic PCR testing (1.7%; 95% CI 0.9-2.9%) and universal masking (24%; 95% CI 3.4-55.5%). Modelling studies showed that combinations of (i) timely and widespread contact tracing and case isolation, (ii) facilitating smaller worker cohorts, and (iii) effective use of PPE can reduce workplace transmission. Comprehensive COVID-19 IPC measures incorporating swift contact tracing and case isolation, PPE, and facility zoning can effectively prevent workplace outbreaks. Masking alone should not be considered sufficient protection from SARS-CoV-2 outbreaks in the workplace.

Citing Articles

Occupational and non-occupational factors of post-COVID-19 condition: a cross-sectional survey in the French general working population.

Rushyizekera M, Delpierre C, Makovski T, Coste J BMJ Public Health. 2025; 3(1):e001613.

PMID: 40017925 PMC: 11816202. DOI: 10.1136/bmjph-2024-001613.


SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, USA, 2021 to 2022.

Gigot C, Pisanic N, Spicer K, Davis M, Kruczynski K, Rivera M Ann Work Expo Health. 2024; 68(8):881-889.

PMID: 39102901 PMC: 11427537. DOI: 10.1093/annweh/wxae067.


Learning from an experience, challenges and approaches in the workplace during COVID-19 pandemic: a content analysis of international documents.

Ghayen M, Faghihi M, Ezati E, Khosravi Y, Almasi A, Farshad A BMC Public Health. 2024; 24(1):1828.

PMID: 38982432 PMC: 11232154. DOI: 10.1186/s12889-024-19251-w.


Distribution of COVID-19 mitigation measures by industry and work arrangement-US blood donors, May 2021-December 2021.

Shi D, Rinsky J, McDonald E, Shah M, Groenewold M, de Perio M Am J Ind Med. 2024; 67(8):764-771.

PMID: 38856006 PMC: 11265519. DOI: 10.1002/ajim.23626.


Investigating Health and Well-Being Challenges Faced by an Aging Workforce in the Construction and Nursing Industries: Computational Linguistic Analysis of Twitter Data.

Li W, Tang L, Montayre J, Harris C, West S, Antoniou M J Med Internet Res. 2024; 26:e49450.

PMID: 38838308 PMC: 11187510. DOI: 10.2196/49450.


References
1.
Juneau C, Pueyo T, Bell M, Gee G, Collazzo P, Potvin L . Lessons from past pandemics: a systematic review of evidence-based, cost-effective interventions to suppress COVID-19. Syst Rev. 2022; 11(1):90. PMC: 9096744. DOI: 10.1186/s13643-022-01958-9. View

2.
Lloyd-Smith J, Schreiber S, Kopp P, Getz W . Superspreading and the effect of individual variation on disease emergence. Nature. 2005; 438(7066):355-9. PMC: 7094981. DOI: 10.1038/nature04153. View

3.
Menting T, Krause K, Benz-Tettey F, Boehringer R, Laufer D, Gruber B . Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?. Int J Hyg Environ Health. 2020; 231:113653. PMC: 7580697. DOI: 10.1016/j.ijheh.2020.113653. View

4.
Agius R, Robertson J, Kendrick D, Sewell H, Stewart M, Mckee M . Covid-19 in the workplace. BMJ. 2020; 370:m3577. DOI: 10.1136/bmj.m3577. View

5.
Grassly N, Pons-Salort M, Parker E, White P, Ferguson N . Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. Lancet Infect Dis. 2020; 20(12):1381-1389. PMC: 7434438. DOI: 10.1016/S1473-3099(20)30630-7. View